The forecast for diuretic medicine sales in Germany reflects a steady growth trajectory from 2024 to 2028. In 2023, the sales stood at 710 million USD. Forecasted values indicate an annual increase, with sales expected to reach 748.9 million USD by 2028.
- 2024: 717.9 million USD (+1.11% YoY)
- 2025: 725.8 million USD (+1.10% YoY)
- 2026: 733.6 million USD (+1.08% YoY)
- 2027: 741.3 million USD (+1.05% YoY)
- 2028: 748.9 million USD (+1.02% YoY)
The compound annual growth rate (CAGR) from 2024 to 2028 is approximately 1.07%.
Future trends to watch for include potential advancements in diuretic medication technology, changes in healthcare policy affecting prescription rates, and demographic shifts leading to an increased demand for such medications.
